MONODAC
C4 Therapeutics, Inc.
Application Filed: 2020-07-13
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90049843 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Douglas R. Wolf |
| Attorney Docket Number | C15072001000 |
Timeline
| 2020-07-13 | Application Filed |
| 2020-08-07 | Location: NEW APPLICATION PROCESSING |
| 2020-08-07 | Status: Live/Pending |
| 2020-08-10 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  C4 Therapeutics, Inc. |
| Address | 490 Arsenal Way, Suite 200 Watertown DE 02472 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
 Application | MULTI | 2020-07-13 |
 Drawing | JPEG | 2020-07-13 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | protein degraders; pharmaceutical products for the prevention and treatment of cancer, tumors, autoimmune disorders, neurological, vascular and infectious diseases; pharmaceutical preparations for immunotherapy |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-08-10 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-10-22 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-10-24 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-10-24 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-10-24 | 5 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-04-23 | 6 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-04-23 | 7 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-04-24 | 8 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-05-06 | 9 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-05-19 | 10 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-06-08 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-06-08 | 12 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-08-03 | 13 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-02-01 | 14 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2022-02-01 | 15 EXT1 S: |
| EXTENSION 1 GRANTED | 2022-02-01 | 16 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-02-03 | 17 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-08-01 | 18 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2022-08-01 | 19 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2022-08-01 | 20 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-08-03 | 21 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2023-01-30 | 22 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2023-01-30 | 23 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2023-01-30 | 24 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-02-01 | 25 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2023-06-27 | 26 EEXT I:Incoming Correspondence |
| SOU EXTENSION 4 FILED | 2023-06-27 | 27 EXT4 S: |
| SOU EXTENSION 4 GRANTED | 2023-06-27 | 28 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-06-29 | 29 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2023-12-05 | 30 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2023-12-13 | 31 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2023-12-05 | 32 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2023-12-13 | 33 SUPC I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2023-12-13 | 34 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2023-12-13 | 35 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2023-12-13 | 36 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2024-03-12 | 37 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2024-06-21 | 38 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-06-21 | 39 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-06-21 | 40 TEME I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2024-07-10 | 41 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2024-07-10 | 42 SUNA E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MONODAC 90430706 not registered Live/Pending |
C4 Therapeutics, Inc. 2020-12-30 |
 MONODAC 90049843 not registered Live/Pending |
C4 Therapeutics, Inc. 2020-07-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 